Deferred Tax Assets, Operating Loss Carryforwards of VBI Vaccines Inc/BC from 31 Dec 2015 to 31 Dec 2023

Taxonomy & unit: us-gaap: USD
Description: Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary: VBI Vaccines Inc/BC quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 31 Dec 2015 to 31 Dec 2023.
VBI Vaccines Inc/BC Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Dec 2023 was $108,574,000, a 11% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)

Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

VBI Vaccines Inc/BC Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2023	$108,574,000	+$10,427,000	+11%	31 Dec 2023	10-K	16 Apr 2024	2023	FY
Q4 2022	$98,147,000	+$11,750,000	+14%	31 Dec 2022	10-K	16 Apr 2024	2023	FY
Q4 2021	$86,397,000	+$15,925,000	+23%	31 Dec 2021	10-K	13 Mar 2023	2022	FY
Q4 2020	$70,472,000	+$16,135,000	+30%	31 Dec 2020	10-K	07 Mar 2022	2021	FY
Q4 2019	$54,337,000	+$12,781,000	+31%	31 Dec 2019	10-K	02 Mar 2021	2020	FY
Q4 2018	$41,556,000	+$9,698,000	+30%	31 Dec 2018	10-K	05 Mar 2020	2019	FY
Q4 2017	$31,858,000	+$3,136,000	+11%	31 Dec 2017	10-K	25 Feb 2019	2018	FY
Q4 2016	$28,722,000	+$23,046,000	+406%	31 Dec 2016	10-K	26 Feb 2018	2017	FY
Q4 2015	$5,676,000			31 Dec 2015	10-K	20 Mar 2017	2016	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.